Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urinary Tract Calculi III: Medical Management

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

Urinary Tract Calculi V: Nursing Management

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...

Urinary Tract Calculi VI: Surgical Management

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prognostic value of platelet indices as determined by ADVIA 120 in patients suspected of having disseminated intravascular coagulation.

International journal of laboratory hematology·2008

Same author

Cell cycle and immune-related processes are significantly altered in chronic GVHD.

Bone marrow transplantation·2008

Same author

Combustion characteristics of simulated gas fuel in a 30 kg/h scale pyrolysis-melting incinerator.

Waste management (New York, N.Y.)·2008

Same author

Chlorpromazine attenuates pancreatic beta-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation.

Journal of psychopharmacology (Oxford, England)·2008

Same author

Intracranial bilateral symmetric calcification in hypoparathyroidism.

Emergency medicine journal : EMJ·2008

Same author

Differential expression of signal transduction factors in ovarian follicle development: a functional role for betaglycan and FIBP in granulosa cells in cattle.

Physiological genomics·2008

Search research articles

Related Experiment Videos

Update on nephrolithiasis management.

L O Long¹, S Park

¹Department of Urology, University of Washington Medical Center, Seattle, WA 98195, USA.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology

|October 4, 2007

Summary

Kidney stone (urolithiasis) recurrence is common, but identifying metabolic abnormalities aids prevention. Targeted medical therapies can prevent stone growth and new stone formation, though some cases remain challenging.

Related Experiment Videos

Area of Science:

Nephrology
Urology
Metabolic Medicine

Background:

Urolithiasis affects 10-15% of the population.
Recurrent kidney stones cause significant morbidity and can lead to chronic kidney disease.
Prevention of stone recurrence is a critical treatment objective.

Purpose of the Study:

To review current pharmacologic treatments for urolithiasis.
To discuss investigational agents for kidney stone prevention.
To highlight the importance of metabolic evaluation in recurrent stone formers.

Main Methods:

Review of selective and nonselective pharmacologic treatments.
Discussion of investigational agents for stone prevention.
Emphasis on metabolic evaluation via 24-hour urine collections and serum tests.

Main Results:

Over 90% of recurrent stone formers have identifiable metabolic abnormalities.
Targeted medical therapy can be initiated based on metabolic evaluation.
Currently available therapies are effective but not universally adequate.

Conclusions:

Metabolic evaluation is crucial for patients at high risk of stone recurrence.
Personalized medical therapy can prevent stone growth and recurrence.
Further research is needed for refractory cases of urolithiasis.